Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

10 févr. 2016 06h50 HE | Source: Insys Therapeutics, Inc.

Insys Therapeutics, Inc. to Present at RBC Capital Markets 2016 Global Healthcare Conference

PHOENIX, Feb. 10, 2016 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (“Insys” or “the Company”) (NASDAQ:INSY) today announced that Santosh Vetticaden, MD, PhD, Chief Medical Officer, and Darryl...
09 févr. 2016 06h50 HE | Source: Insys Therapeutics, Inc.

Insys Therapeutics Enrolls First Patient in Phase II Study for the Treatment of Infantile Spasms Using Pharmaceutical CBD

PHOENIX, Feb. 09, 2016 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (NASDAQ:INSY) ("Insys" or "the Company") today announced that the Company has enrolled the first patient in a Phase II clinical...
03 févr. 2016 16h30 HE | Source: Insys Therapeutics, Inc.

Insys Therapeutics to Report Fourth Quarter and Full Year 2015 Results

PHOENIX, Feb. 03, 2016 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (NASDAQ:INSY) (“Insys” or “Company”) today announced that the Company will release its financial results for the fourth quarter...
25 janv. 2016 12h54 HE | Source: Insys Therapeutics, Inc.

Insys Therapeutics Releases Statement on Its Patient Services Center

PHOENIX, Jan. 25, 2016 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (Nasdaq:INSY) (“Insys” or “the Company”) today issued the following statement in response to misleading reports in the media...
30 déc. 2015 07h00 HE | Source: Insys Therapeutics, Inc.

Insys Therapeutics, Inc. to Present at J.P. Morgan 34th Annual Healthcare Conference

PHOENIX, Dec. 30, 2015 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (“Insys” or “the Company”) (NASDAQ:INSY) today announced that Dan Brennan, Chief Operating Officer, and Darryl Baker, Chief...
04 déc. 2015 07h00 HE | Source: Insys Therapeutics, Inc.

Insys Therapeutics Responds to False and Misleading Report

PHOENIX, Dec. 04, 2015 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (Nasdaq:INSY) (“Insys” or “the Company”) today issued the following response to a recent report containing accusations centered...
02 déc. 2015 07h30 HE | Source: Insys Therapeutics, Inc.

Insys Therapeutics, Inc. Announces Speakers for December 3, 2015 Investor Day

PHOENIX, Ariz., Dec. 02, 2015 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (“Insys”) (NASDAQ:INSY) today announced the presenting speakers for its Investor Day to be held on Thursday, December 3,...
24 nov. 2015 07h00 HE | Source: Insys Therapeutics, Inc.

Insys Therapeutics, Inc. to Host Investor Day on December 3, 2015

PHOENIX, Nov. 24, 2015 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (“Insys” or “the Company”) (NASDAQ:INSY) today announced that the Company will hold its Investor Day from 8:30 a.m. to 11:30...
23 nov. 2015 16h30 HE | Source: Insys Therapeutics, Inc.

Insys Therapeutics, Inc. to Present at Piper Jaffray 27th Annual Healthcare Conference

PHOENIX, Nov. 23, 2015 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (“Insys” or “the Company”) (NASDAQ:INSY) today announced that Dan Brennan, Chief Operating Officer, and Darryl Baker, Chief...
23 nov. 2015 12h47 HE | Source: Insys Therapeutics, Inc.

Insys Therapeutics, Inc. Issues Statement

PHOENIX, Nov. 23, 2015 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (“Insys” or “the Company”) (NASDAQ:INSY) today issued the following statement: INTRODUCTION Insys is committed to developing...

Page précédente